This clinical trial is focused on children undergoing surgery with a type of pain relief called locoregional anesthesia, which numbs a specific area of the body. The study is investigating the effects of a medication called dexmedetomidine, which is given through a vein (intravenously) to help manage pain after surgery. The trial aims to see how well dexmedetomidine works when used alongside locoregional anesthesia in reducing pain for children after their operations.

In this study, some children will receive dexmedetomidine, while others will receive a placebo, which is a solution that does not contain the active medication. The study is designed to be double-blind, meaning neither the participants nor the researchers know who is receiving the actual medication or the placebo, to ensure unbiased results. The main goal is to observe if fewer children need additional pain relief medication after surgery when they receive dexmedetomidine.

Throughout the study, researchers will monitor the children’s pain levels and any side effects they might experience. They will also look at how much additional pain medication is needed and how long the children stay in the recovery area after surgery. The study will also assess the children’s behavior and quality of life after they leave the hospital, at intervals of 7 days, 3 months, and 6 months. This information will help determine the effectiveness and safety of using dexmedetomidine in pediatric surgeries.